SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950135-07-001741
Filing Date
2007-03-20
Accepted
2007-03-20 07:54:43
Documents
4

Document Format Files

Seq Description Document Type Size
1 LA JOLLA PHARMACEUTICAL COMPANY b64621b5e424b5.htm 424B5 351008
2 GRAPHIC b64621b5b6462108.gif GRAPHIC 1835
3 GRAPHIC b64621b5b6462111.gif GRAPHIC 1687
4 GRAPHIC b64621b5b6462110.gif GRAPHIC 590
  Complete submission text file 0000950135-07-001741.txt   358513
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-101499 | Film No.: 07705072
SIC: 2836 Biological Products, (No Diagnostic Substances)